E. Campo and S. Rule, Mantle cell lymphoma: evolving management strategies, Blood, vol.125, issue.1, pp.48-55, 2014.
DOI : 10.1182/blood-2014-05-521898
URL : http://www.bloodjournal.org/content/bloodjournal/125/1/48.full.pdf

A. Inamdar, A. Goy, and N. Ayoub, Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents, Oncotarget, vol.7, issue.30, pp.48692-48731, 2016.
DOI : 10.18632/oncotarget.8961

K. Shain, W. Dalton, and J. Tao, The tumor microenvironment shapes hallmarks of mature B-cell malignancies, Oncogene, vol.23, issue.36, pp.4673-4682, 2015.
DOI : 10.1016/j.ccr.2012.12.003

K. Yakimchuk, M. Jondal, and S. Okret, Estrogen receptor ?? and ?? in the normal immune system and in lymphoid malignancies, Molecular and Cellular Endocrinology, vol.375, issue.1-2, pp.121-129, 2013.
DOI : 10.1016/j.mce.2013.05.016

K. Yakimchuk, M. Hasni, and J. Guan, Inhibition of lymphoma vascularization and dissemination by estrogen receptor ?? agonists, Blood, vol.123, issue.13, pp.2054-2061, 2014.
DOI : 10.1182/blood-2013-07-517292

S. Chaudhary, T. Singh, and S. Talwelkar, Erb-041, an Estrogen Receptor-?? Agonist, Inhibits Skin Photocarcinogenesis in SKH-1 Hairless Mice by Downregulating the WNT Signaling Pathway, Cancer Prevention Research, vol.7, issue.2, pp.186-198, 2014.
DOI : 10.1158/1940-6207.CAPR-13-0276

J. Burger and R. Ford, The microenvironment in mantle cell lymphoma: Cellular and molecular pathways and emerging targeted therapies, Seminars in Cancer Biology, vol.21, issue.5, pp.308-312, 2011.
DOI : 10.1016/j.semcancer.2011.09.006

M. Fidalgo, B. Younes, K. Body, S. , B. Aissa-fennira et al., Agonists of estrogen receptor ? have limited anti-myelome activity. Blood e-Letters, 2015.

E. Ladikou and K. E. , The emerging role of estrogen in B cell malignancies, Leukemia & Lymphoma, vol.224, issue.11, pp.528-539, 2017.
DOI : 10.1038/sj.leu.2403043

A. Moros, S. Bustany, and J. Cahu, Antitumoral Activity of Lenalidomide in In Vitro and In Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes, Clinical Cancer Research, vol.20, issue.2, pp.393-403, 2014.
DOI : 10.1158/1078-0432.CCR-13-1569

E. Campo and S. Rule, Mantle cell lymphoma: evolving management strategies, Blood, vol.125, issue.1, pp.48-55, 2014.
DOI : 10.1182/blood-2014-05-521898
URL : http://www.bloodjournal.org/content/bloodjournal/125/1/48.full.pdf

A. Inamdar, A. Goy, and N. Ayoub, Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents, Oncotarget, vol.7, issue.30, pp.48692-48731, 2016.
DOI : 10.18632/oncotarget.8961

K. Shain, W. Dalton, and J. Tao, The tumor microenvironment shapes hallmarks of mature B-cell malignancies, Oncogene, vol.23, issue.36, pp.4673-4682, 2015.
DOI : 10.1016/j.ccr.2012.12.003

K. Yakimchuk, M. Jondal, and S. Okret, Estrogen receptor ?? and ?? in the normal immune system and in lymphoid malignancies, Molecular and Cellular Endocrinology, vol.375, issue.1-2, pp.121-129, 2013.
DOI : 10.1016/j.mce.2013.05.016

K. Yakimchuk, M. Hasni, and J. Guan, Inhibition of lymphoma vascularization and dissemination by estrogen receptor ?? agonists, Blood, vol.123, issue.13, pp.2054-2061, 2014.
DOI : 10.1182/blood-2013-07-517292

S. Chaudhary, T. Singh, and S. Talwelkar, Erb-041, an Estrogen Receptor-?? Agonist, Inhibits Skin Photocarcinogenesis in SKH-1 Hairless Mice by Downregulating the WNT Signaling Pathway, Cancer Prevention Research, vol.7, issue.2, pp.186-198, 2014.
DOI : 10.1158/1940-6207.CAPR-13-0276

J. Burger and R. Ford, The microenvironment in mantle cell lymphoma: Cellular and molecular pathways and emerging targeted therapies, Seminars in Cancer Biology, vol.21, issue.5, pp.308-312, 2011.
DOI : 10.1016/j.semcancer.2011.09.006

M. Fidalgo, B. Younes, K. Body, S. , B. Aissa-fennira et al., Agonists of estrogen receptor ? have limited anti-myelome activity. Blood e-Letters, 2015.

E. Ladikou and K. E. , The emerging role of estrogen in B cell malignancies, Leukemia & Lymphoma, vol.224, issue.11, pp.528-539, 2017.
DOI : 10.1038/sj.leu.2403043

A. Moros, S. Bustany, and J. Cahu, Antitumoral Activity of Lenalidomide in In Vitro and In Vivo Models of Mantle Cell Lymphoma Involves the Destabilization of Cyclin D1/p27KIP1 Complexes, Clinical Cancer Research, vol.20, issue.2, pp.393-403, 2014.
DOI : 10.1158/1078-0432.CCR-13-1569